1l96

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1l96" size="450" color="white" frame="true" align="right" spinBox="true" caption="1l96, resolution 2.0&Aring;" /> '''STRUCTURE OF A HINGE-...)
Line 1: Line 1:
-
[[Image:1l96.jpg|left|200px]]<br /><applet load="1l96" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1l96.jpg|left|200px]]<br /><applet load="1l96" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1l96, resolution 2.0&Aring;" />
caption="1l96, resolution 2.0&Aring;" />
'''STRUCTURE OF A HINGE-BENDING BACTERIOPHAGE T4 LYSOZYME MUTANT, ILE3-> PRO'''<br />
'''STRUCTURE OF A HINGE-BENDING BACTERIOPHAGE T4 LYSOZYME MUTANT, ILE3-> PRO'''<br />
==Overview==
==Overview==
-
The mutant T4 phage lysozyme in which isoleucine 3 is replaced by proline, (I3P) crystallizes in an orthorhombic form with two independent molecules, in the asymmetric unit. Relative to wild-type lysozyme, which crystallizes, in a trigonal form, the two I3P molecules undergo large hinge-bending, displacements with the alignments of the amino-terminal and, carboxy-terminal domains changed by 28.9 degrees and 32.9 degrees, respectively. The introduction of the mutation, together with the, hinge-bending displacement, is associated with repacking of the, side-chains of Phe4, Phe67 and Phe104. These aromatic residues are, clustered close to the site of the mutation and are at the junction, between the amino and carboxyl-terminal domains. As a result of this, structural rearrangement the side-chain of Phe4 moves from a relatively, solvent-exposed conformation to one that is largely buried. Mutant I3P, also crystallizes in the same trigonal form as wild-type and, in this, case, the observed structural changes are restricted to the immediate, vicinity of the replacement. The main change is a shift of 0.3 to 0.5 A in, the backbone of residues 1 to 5. The ability to crystallize I3P under, similar conditions but in substantially different conformations suggests, that the molecule undergoes large-scale hinge-bending displacements in, solution. It is also likely that these conformational excursions are, associated with repacking at the junction of the N-terminal and C-terminal, domains. On the other hand, the analysis is complicated by possible, effects of crystal packing. The different I3P crystal structures show, substantial differences in the binding of solvent, both at the site of the, Ile3--&gt;Pro replacement and at other internal sites.
+
The mutant T4 phage lysozyme in which isoleucine 3 is replaced by proline (I3P) crystallizes in an orthorhombic form with two independent molecules in the asymmetric unit. Relative to wild-type lysozyme, which crystallizes in a trigonal form, the two I3P molecules undergo large hinge-bending displacements with the alignments of the amino-terminal and carboxy-terminal domains changed by 28.9 degrees and 32.9 degrees, respectively. The introduction of the mutation, together with the hinge-bending displacement, is associated with repacking of the side-chains of Phe4, Phe67 and Phe104. These aromatic residues are clustered close to the site of the mutation and are at the junction between the amino and carboxyl-terminal domains. As a result of this structural rearrangement the side-chain of Phe4 moves from a relatively solvent-exposed conformation to one that is largely buried. Mutant I3P also crystallizes in the same trigonal form as wild-type and, in this case, the observed structural changes are restricted to the immediate vicinity of the replacement. The main change is a shift of 0.3 to 0.5 A in the backbone of residues 1 to 5. The ability to crystallize I3P under similar conditions but in substantially different conformations suggests that the molecule undergoes large-scale hinge-bending displacements in solution. It is also likely that these conformational excursions are associated with repacking at the junction of the N-terminal and C-terminal domains. On the other hand, the analysis is complicated by possible effects of crystal packing. The different I3P crystal structures show substantial differences in the binding of solvent, both at the site of the Ile3--&gt;Pro replacement and at other internal sites.
==About this Structure==
==About this Structure==
-
1L96 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bacteriophage_t4 Bacteriophage t4] with CL and BME as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1L96 OCA].
+
1L96 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bacteriophage_t4 Bacteriophage t4] with <scene name='pdbligand=CL:'>CL</scene> and <scene name='pdbligand=BME:'>BME</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1L96 OCA].
==Reference==
==Reference==
Line 15: Line 15:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Dixon, M.]]
[[Category: Dixon, M.]]
-
[[Category: Matthews, B.W.]]
+
[[Category: Matthews, B W.]]
[[Category: Shewchuk, L.]]
[[Category: Shewchuk, L.]]
[[Category: BME]]
[[Category: BME]]
Line 21: Line 21:
[[Category: hydrolase(o-glycosyl)]]
[[Category: hydrolase(o-glycosyl)]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 20:23:25 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:42:48 2008''

Revision as of 11:42, 21 February 2008


1l96, resolution 2.0Å

Drag the structure with the mouse to rotate

STRUCTURE OF A HINGE-BENDING BACTERIOPHAGE T4 LYSOZYME MUTANT, ILE3-> PRO

Overview

The mutant T4 phage lysozyme in which isoleucine 3 is replaced by proline (I3P) crystallizes in an orthorhombic form with two independent molecules in the asymmetric unit. Relative to wild-type lysozyme, which crystallizes in a trigonal form, the two I3P molecules undergo large hinge-bending displacements with the alignments of the amino-terminal and carboxy-terminal domains changed by 28.9 degrees and 32.9 degrees, respectively. The introduction of the mutation, together with the hinge-bending displacement, is associated with repacking of the side-chains of Phe4, Phe67 and Phe104. These aromatic residues are clustered close to the site of the mutation and are at the junction between the amino and carboxyl-terminal domains. As a result of this structural rearrangement the side-chain of Phe4 moves from a relatively solvent-exposed conformation to one that is largely buried. Mutant I3P also crystallizes in the same trigonal form as wild-type and, in this case, the observed structural changes are restricted to the immediate vicinity of the replacement. The main change is a shift of 0.3 to 0.5 A in the backbone of residues 1 to 5. The ability to crystallize I3P under similar conditions but in substantially different conformations suggests that the molecule undergoes large-scale hinge-bending displacements in solution. It is also likely that these conformational excursions are associated with repacking at the junction of the N-terminal and C-terminal domains. On the other hand, the analysis is complicated by possible effects of crystal packing. The different I3P crystal structures show substantial differences in the binding of solvent, both at the site of the Ile3-->Pro replacement and at other internal sites.

About this Structure

1L96 is a Single protein structure of sequence from Bacteriophage t4 with and as ligands. Active as Lysozyme, with EC number 3.2.1.17 Full crystallographic information is available from OCA.

Reference

Structure of a hinge-bending bacteriophage T4 lysozyme mutant, Ile3-->Pro., Dixon MM, Nicholson H, Shewchuk L, Baase WA, Matthews BW, J Mol Biol. 1992 Oct 5;227(3):917-33. PMID:1404394

Page seeded by OCA on Thu Feb 21 13:42:48 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools